Early and accurate detection of cancer starts here. Exai Bio’s next-generation RNA-based platform delivers actionable insight into cancer biology from a simple blood draw.
Keep scrolling to learn what makes our platform unique
Exai is revolutionizing how we diagnose, treat, and manage cancer.
Using our novel RNA biomarkers, we found signals in what appeared to others as noise. With these biomarkers and AI, we have connected the dots, finding actionable clinical insights that weren't possible before.
